<DOC>
	<DOCNO>NCT02419989</DOCNO>
	<brief_summary>No nontuberculosis mycobacteria ( NTM ) treatment protocol validate set cystic fibrosis ( CF ) . This trial test feasibility standardize treatment algorithm confirm disease either M. avium complex M. abscessus complex also base forthcoming guideline CF Foundation ( CFF ) European CF Society ( ECFS ) . The primary endpoint 12 month negative NTM culture follow completion therapy . The investigator ' near-term goal validate protocol extend trial 5 additional CF Centers . The long-term goal make validated protocol available entire CFF Care Center Network .</brief_summary>
	<brief_title>PATIENCE Trial : Prospective Algorithm Treatment NTM Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>1 . Male female subject confirm diagnosis CF , define : sweat chloride value â‰¥60 mmol/L quantitative pilocarpine iontophoresis , OR 2 CF cause mutation ( document subject 's medical record ) , AND chronic sinopulmonary disease OR gastrointestinal/nutritional abnormality 2 . Age 7 year great 3 . Able understand comply protocol requirement , restriction , instruction likely complete study plan , judge investigator 4 . Signed informed consent , appropriate , sign assent form 5 . Diagnosis NTM disease 6 . Intention treat NTM disease , base judgment CF clinic physician patient may benefit treatment 7 . Previous sign informed consent allow medical record enter CF Foundation Patient Registry 1 . Presence condition abnormality opinion investigator would compromise safety subject quality data 2 . Pregnant 3 . History solid organ hematological transplantation 4 . Currently undergo treatment NTM infection 5 . Patient treatment failure current NTM specie , define positive sputum culture within 12 month discontinuation antibiotic treatment</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Nontuberculous Mycobacteria</keyword>
</DOC>